---
schema_version: "secwatch.filing_event.v1"
accession: "0001528287-26-000027"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2026-08-11T20:07:42+00:00"
generated_at: "2026-08-11T20:09:32.523447+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NeuroPace Q2 revenue $22.8M (+17% YoY); raises FY26 revenue guidance

## Summary
- Q2 2026 RNS revenue $22.5M, up 21.3% YoY; total revenue $22.8M vs $19.5M in Q2 2025.
- GAAP net loss narrowed to ($6.2)M from ($10.0)M YoY; Adjusted EBITDA loss improved to ($2.8)M from ($4.9)M.
- FY26 revenue guidance raised to $99.5M-$101.5M (from $99M-$101M); Adjusted EBITDA guided to ($7.5)M-($8.5)M.
- Launched ECoG Assistant AI decision-support tool; NAUTILUS 18-month data showed 77% median GTC seizure reduction.
- Cash $51.9M at June 30, 2026; DIXI product operations presented as discontinued; long-term borrowings $59.0M.

## SEC filing metadata
- accession: 0001528287-26-000027
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2026-08-11T20:07:42+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000027/0001528287-26-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000152828726000027/npce-20260811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001528287-26-000027
- JSON: https://secwatch.observer/filing/0001528287-26-000027.json
- Plain text: https://secwatch.observer/filing/0001528287-26-000027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.